| (1) |
Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid
disorders in the com-munity: a twenty-year follow-up of the Whick-ham survey.
Clin Endocrinol. 1995; 43: 55-68. |
| (2) |
Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines
for patients with hyperthyroidism and hypothyroidism. JAMA.1995; 273: 808-812. |
| (3) |
Trivalle C, Doucet J, Chassagne P, et al. Differences in the signs and
symptoms of hyperthy-roidism in older and younger patients. J Am Geriatr
Soc.1996; 44: 50-53. |
| (4) |
Franklyn JA, Black EG, Betteridge J, Sheppard MC. Comparison of second
and third generation methods for measurement of serum thyrotropin in patients
with overt hyperthyroidism, patients receiving thyroxine therapy, and those
with nonthyroidal illness. J Clin Endocrinol Metab.1994; 78: 1368-1371. |
| (5) |
Okamura K, Ikenoue H, Shiroozu A, Sato K, Yoshinari M, Fujishima M. Reevaluation
of the effects of methylmercaptoimidazole and propylthioura-cilin patients
with Graves' hyperthyroidism. J Clin Endocrinol Metab.1987; 65: 719-723. |
| (6) |
Tamai H, Hayaki I, Kawai K, et al. Lack of effect of thyroxine administration
on elevated thyroid stimulating hormone receptor antibody levels in treated
Graves' disease patients. J Clin Endocrinol Metab. 1995; 80: 1481-1484. |
| (7) |
McIver B, Rae P, Beckett G, Wilkinson E, Gold A, Toft A. Lack of effect
of thyroxine in patients with Graves' hyperthyroidism who are treated with
an an-tithyroid drug. N Engl J Med.1996; 334: 220-224. |
| (8) |
Lucas A, Salinas I, Rius F, et al. Medical therapy of Graves' disease:
does thyroxine prevent recur-renceof hyperthyroidism? J Clin Endocrinol
Metab. 1997; 82: 2410-2413. |
| (9) |
Rittmaster RS, Abbott EC, Douglas R, et al. Effect of methimazole, with
or without L-thyroxine, on remission rates in Graves' disease. J Clin Endocrinol
Metab.1998; 83: 814-818. |
| (10) |
Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for
hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med.1998;
338: 73-78. |
| (11) |
Bartalena L, Marcocci C, Tanda ML, et al. Cigarette smoking and treatment
outcomes in Graves' ophthalmopathy. Ann Intern Med.1998; 129: 632-635. |
| (12) |
Tuttle RM, Patience T, Budd S. Treatment with propylthiouracil before
radioactive iodine therapy is associated with a higher treatment failure
rate than therapy with radioactive iodine alone in Graves' disease. Thyroid.1995;
5: 243-247. |
| (13) |
Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Vanmiddlesworth NR.
Pretreatment with pro-pylthiouracil but not methimazole reduces the therapeutic
efficacy of iodine-131 in hyperthy-roidism. J Clin Endocrinol Metab.1998;
83: 685-687. |
| (14) |
Holm L-E, Hall P, Wiklund K, et al. Cancer risk after iodine-131 therapy
for hyperthyroidism. J Natl Cancer Inst.1991; 83: 1072-1077. |
| (15) |
Mortimer RH, Cannell GR, Addison RS, Johnson LP, Roberts MS, Bernus I.
Methimazole and proplythiouracil equally cross the perfused human term placental
lobule. J Clin Endocrinol Metab.1997; 82: 3099-3102. |
| (16) |
Azizi F. Effect of methimazole treatment of maternal thyrotoxicosis on
thyroid function in breast-feeding infants. J Pediatr.1996; 128: 855-858. |
| (17) |
Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern
Med.1997; 126: 63-73. |
| (18) |
Baker JR Jr. Autoimmune endocrine disease. JAMA.1997; 278: 1931-1937. |
| (19) |
Bernstein R, Muller C, Midtbo K, Smith G, Haug E, Hertzenberg L. Silent
myocardial ischemia in hypothyroidism. Thyroid.1995; 5: 443-447. |
| (20) |
Liel Y, Harman-Boehm I, Shany S. Evidence for a clinically important adverse
effect of fiber-enriched diet on the bioavailability of levothyrox-inein
adult hypothyroid patients. J Clin Endocrinol Metab.1996; 80: 857-859. |
| (21) |
Mandel S, Brent GA, Larsen PR. Levothyroxine therapy in patients with
thyroid disease. Ann Intern Med. 1993; 119: 492-502. |
| (22) |
Greenspan SL, Greenspan FS. The effect of thyroid hormone on skeletal
integrity. Ann Intern Med.1999; 130: 750-758. |
| (23) |
Ching GW, Franklyn JA, Stallard TJ, Daykin J, Sheppard MC, Gammage MD.
Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis.
Heart.1996; 75: 363-368. |
| (24) |
Woeber KA. Subclinical thyroid dysfunction. Arch Intern Med.1997; 157:
1065-1068. |